Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ancora-SB

K-Number: K260314 · 2026-05-01

Decision Date2026-05-01
Product CodeFDA
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Ancora-SB is a medical device manufactured by Aspero Medical, Inc.. It received FDA 510(k) clearance on 2026-05-01 under approval number K260314. The device is classified under product code FDA. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ancora-SB?

Ancora-SB is a medical device that received FDA 510(k) clearance on 2026-05-01. It is manufactured by Aspero Medical, Inc.. The 510(k) number is K260314.

When was Ancora-SB approved by the FDA?

Ancora-SB received FDA 510(k) clearance on 2026-05-01, under approval number K260314.

What company makes Ancora-SB?

Ancora-SB is manufactured by Aspero Medical, Inc..

What is the FDA product code for Ancora-SB?

The FDA product code for Ancora-SB is FDA.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.